Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Going global: the report of the 2009-2010 Research and Graduate Affairs Committee.

Audus KL, Moreton JE, Normann SA, Sands CD 3rd, Seaba HH, Wincor MZ, Sagraves R, Miller KW; Research and Graduate Affairs Committee.

Am J Pharm Educ. 2010 Dec 15;74(10):S8. No abstract available.

2.

Antiepileptic drug treatment of nonconvulsive seizures induced by experimental focal brain ischemia.

Williams AJ, Tortella FC, Lu XM, Moreton JE, Hartings JA.

J Pharmacol Exp Ther. 2004 Oct;311(1):220-7. Epub 2004 May 12.

PMID:
15140918
3.

The pharmacokinetics and electroencephalogram response of remifentanil alone and in combination with esmolol in the rat.

Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, Eddington ND.

Pharm Res. 1997 Dec;14(12):1817-23.

PMID:
9453074
4.

Evaluating a possible pharmacokinetic interaction between remifentanil and esmolol in the rat.

Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, Eddington ND.

J Pharm Sci. 1997 Nov;86(11):1278-82.

PMID:
9383740
5.

EEG spectral analysis of the neuroprotective kappa opioids enadoline and PD117302.

Tortella FC, Rose J, Robles L, Moreton JE, Hughes J, Hunter JC.

J Pharmacol Exp Ther. 1997 Jul;282(1):286-93.

PMID:
9223566
6.

Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons.

Klette KL, Lin Y, Clapp LE, DeCoster MA, Moreton JE, Tortella FC.

Brain Res. 1997 May 9;756(1-2):231-40.

PMID:
9187337
7.

Role of calcium in sigma-mediated neuroprotection in rat primary cortical neurons.

Klette KL, DeCoster MA, Moreton JE, Tortella FC.

Brain Res. 1995 Dec 15;704(1):31-41.

PMID:
8750959
8.
9.

Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat.

Hubner CB, Moreton JE.

Psychopharmacology (Berl). 1991;105(2):151-6.

PMID:
1839063
10.

Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.

Marquis KL, Paquette NC, Gussio RP, Moreton JE.

J Pharmacol Exp Ther. 1989 Dec;251(3):1104-12.

PMID:
2557412
11.

Cortical EEG changes during the self-administration of phencyclinoids.

Marquis KL, Gussio R, Webb MG, Moreton JE.

Neuropharmacology. 1989 Nov;28(11):1193-8.

PMID:
2594165
12.

Effects of self-administered phencyclidine on regional uptake of 2-deoxy-D-[1-14C]glucose in brain.

Weissman AD, Marquis KL, Moreton JE, London ED.

Neuropharmacology. 1989 Jun;28(6):575-83.

PMID:
2755563
13.

Effects of fixed ratio size and dose on phencyclidine self-administration by rats.

Marquis KL, Webb MG, Moreton JE.

Psychopharmacology (Berl). 1989;97(2):179-82.

PMID:
2498926
14.

Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.

Mattia A, Marquis KL, Leccese AP, el-Fakahany EE, Moreton JE.

J Pharmacol Exp Ther. 1988 Aug;246(2):797-802.

PMID:
2841454
15.

Animal models of intravenous phencyclinoid self-administration.

Marquis KL, Moreton JE.

Pharmacol Biochem Behav. 1987 Jun;27(2):385-9.

PMID:
3628455
16.

The anticonvulsant and behavioral effects of phencyclidine and ketamine following chronic treatment in rats.

Leccese AP, Marquis KL, Mattia A, Moreton JE.

Behav Brain Res. 1986 Dec;22(3):257-64.

PMID:
3790247
17.
18.

Behavioral and receptor binding studies of phencyclidine (PCP) and lithium interaction in the rat.

Mattia A, el-Fakahany EE, Moreton JE.

Life Sci. 1986 Mar 17;38(11):975-84.

PMID:
3005791
19.

The convulsant and anticonvulsant effects of phencyclidine (PCP) and PCP analogues in the rat.

Leccese AP, Marquis KL, Mattia A, Moreton JE.

Behav Brain Res. 1986 Feb;19(2):163-9.

PMID:
3964407
20.

Electroencephalographic (EEG), psychopharmacological, and receptor-binding profiles of 'phencyclinoids'.

Mattia A, Leccese AP, Marquis KL, el-Fakahany EE, Moreton JE.

NIDA Res Monogr. 1986;64:94-111. No abstract available.

PMID:
3012348
21.

Differential electroencephalographic and behavioral cross tolerance to morphine and methadone in the l-alpha-acetylmethadol (LAAM)-maintained rat.

Lukas SE, Moreton JE, Khazan N.

J Pharmacol Exp Ther. 1982 Mar;220(3):561-7. No abstract available.

PMID:
7199573
22.

Effects of levo-alpha-acetylmethadol (LAAM) on morphine self-administration in the rat.

Lukas SE, Moreton JE, Khazan N.

Psychopharmacology (Berl). 1981;73(1):12-6.

PMID:
6785783
23.
24.

Effects of buprenorphine, a new narcotic agonist-antagonist analgesic on the EEG, power spectrum and behavior of the rat.

Kareti S, Moreton JE, Khazan N.

Neuropharmacology. 1980 Feb;19(2):195-201. No abstract available.

PMID:
7360334
25.

D-ala2-methionine-enkephalinamide self-administration in the morphine-dependent rat.

Tortella FC, Moreton JE.

Psychopharmacology (Berl). 1980;69(2):143-7.

PMID:
6779307
26.

A technique for chronic intragastric drug administration in the rat.

Lukas SE, Moreton JE.

Life Sci. 1979 Aug 13;25(7):593-600. No abstract available.

PMID:
502752
27.
29.

Electroencephalographic and behavioral effects of D-ala2-methionine-enkephalinamide and morphine in the rat.

Tortella FC, Moreton JE, Khazan N.

J Pharmacol Exp Ther. 1978 Sep;206(3):636-43.

PMID:
702326
30.

Electroencephalographic and behavioral tolerance and cross-tolerance to morphine and methadone in the rat.

Meltzer LT, Moreton JE, Khazan N.

Toxicol Appl Pharmacol. 1978 Sep;45(3):837-44. No abstract available.

PMID:
214899
31.

Ketamine self-administration by the rhesus monkey.

Moreton JE, Meisch RA, Stark L, Thompson T.

J Pharmacol Exp Ther. 1977 Nov;203(2):303-9.

PMID:
409837
32.

Head-shake distributions during self-maintained dependence on morphine, methadone, and l-alpha-acetylmethadol (LAAM) in the rat.

Chiba S, Young GA, Moreton JE, Khazan N.

Psychopharmacology (Berl). 1977 Aug 31;54(1):105-7.

PMID:
410055
33.

1-alpha-acetylmethadol (LAAM), methadone and morphine abstinence in dependent rats: EEG and behavioral correlates.

Young GA, Moreton JE, Meltzer LT, Khazan N.

Drug Alcohol Depend. 1977 Mar;2(2):141-8.

PMID:
192530
34.

Duration of action of naloxone subcutaneous pellets in antagonizing the EEG and operant behavioural effects of morphine in the rat.

Young GA, Moreton JE, Khazan N.

J Pharm Pharmacol. 1976 Aug;28(8):658-60. No abstract available.

PMID:
11323
35.

Drug self-administration and sleep-awake activity in rats dependent on morphine, methadone, or l-alpha-acetylmethadol.

Moreton JE, Roehrs T, Khazan N.

Psychopharmacology (Berl). 1976 Jun 23;47(3):237-41.

PMID:
823559
36.

REM sleep distributions in post-addict rats relapsing to morphine self-administration: effects of naloxone subcutaneous pellets.

Young GA, Moreton JE, Meltzer L, Khazan N.

Res Commun Chem Pathol Pharmacol. 1975 Jul;11(3):355-63.

PMID:
168624
37.

Effects of naloxone subcutaneous pellets on relapse to morphine self-administration in post-addict rats.

Moreton JE, Young GA, Meltzer L, Khazan N.

Res Commun Chem Pathol Pharmacol. 1975 Jun;11(2):209-19.

PMID:
1171514
38.

Electroencephalographic study of the effects of tetrahydrocannabinols on sleep in the rat.

Moreton JE, Davis WM.

Neuropharmacology. 1973 Sep;12(9):897-907. No abstract available.

PMID:
4355678
39.

A simple method for the preparation of injectables of tetrahydrocannabinols and cannabis extracts.

Moreton JE, Davis WM.

J Pharm Pharmacol. 1972 Feb;24(2):176. No abstract available.

PMID:
4401981
40.

Marihuana on locomotor activity: biphasic effect and tolerance development.

Davis WM, Moreton JE, King WT, Pace HB.

Res Commun Chem Pathol Pharmacol. 1972 Jan;3(1):29-35. No abstract available.

PMID:
5030706

Supplemental Content

Loading ...
Support Center